The use of QUTENZA TM in standard clinical practice: a phase IV, multicentre, European non-interventional study
Phase of Trial: Phase IV
Latest Information Update: 08 Oct 2014
At a glance
- Drugs Capsaicin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Acronyms ASCEND
- Sponsors Astellas Pharma Europe Ltd
- 05 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 19 Mar 2014 Planned End Date changed from 1 Feb 2014 to 1 Jul 2014 as reported by ClinicalTrials.gov record.
- 31 Oct 2013 Planned end date changed from 1 Feb 2012 to 1 Feb 2014 as reported by ClinicalTrials.gov.